Abstract
We became aware of the disorder, immunoblastic lymphadenopathy (IBL), during the course of our study of Hodgkin’s disease cases from World War II at the Armed Forces Institute of Pathology [6] when we were concerned with its resemblance to Hodgkin’s disease. A number of years were required to accumulate a sufficient number of acceptable cases of IBL with follow-up information to determine its clinical expressions and prognostic significance. The findings were presented finally at several meetings in 1973 [9, 10] and subsequently published as a series of 32 cases in early 1975 [11]. These cases collected from hospitals throughout the United States had been investigated clinically in a variable fashion, but nevertheless permitted the presentation of a rather distinctive clinical morphologic entity as a benign appearing hyperimmune proliferation of the B-cell system with distinctive morphologic features. It frequently was initially manifested by hypersensitivity reactions to therapeutic agents (35%), with a dramatic onset of fever, rash and pruritus, and later by generalized lymphadenopathy, and less frequently hepatosplenomegaly. Anemia was common and there was a consistent polyclonal hyperglobulinemia. A lymphoma of transformed lymphocytes, immunoblastic sarcoma (IBS), developed in the subsequent course of disease in three cases and justified consideration of IBL as a prelymphomatous disorder. We have now collected histologic material in over 250 cases of IBL and related disorders, approximately 100 of which fulfill the criteria we originally proposed for IBL; 25 of the latter cases have exhibited features of both IBL and IBS, either in subsequent specimens or in different areas of the initial biopsy. From this experience, it appears that there is a broad spectrum of as yet undefined abnormal immune reactions of which IBL represents the most extreme and abnormal component.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Frizzera, G., Moran, E. M., Rappaport, H.: Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet 7, 1070–1073 (1974).
Frizzera, G., Moran, E. M., Rappaport, H.: Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course. Am. J. Med. 59 ,803–818 (1975).
Hossfeld, D. K., Hoffken, K., Schmidt, C. G., Diedrichs, H.: Chromosome abnormalities in angioimmunoblastic lymphadenopathy. Lancet 7, 198 (1976).
Krueger, G., Malmgren, R. A., Berard, C. W.: Malignant lymphomas and plasmacytosis in mice under chronic immunosuppression and persistent antigenic stimulation. Transplantation 77, 138–144 (1971).
Lukes, R. J.: Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin’s disease. Cancer Res. 57, 1755–1767 (1971).
Lukes, R. J., Butler, J. J., Hicks, E. B.: Natural history of Hodgkin’s disease as related to its pathologic picture. Cancer 79, 317–344 (1966).
Lukes, R. J., Collins, R. D.: Immunologic characterization of human malignant lymphomas. Cancer 34 ,1488–1503 (1974).
Lukes, R. J., Collins, R. D.: New approaches to the classification of the lymphomata. Br. J. Cancer 31 ,suppl. II, 1–28 (1975).
Lukes, R. J., Tindle, B. H.: Immunoblastic lymphadenopathy. Presented at meeting of Pathology Panel and Repository Center for Lymphoma Clinical Trials, National Cancer Institute, Bethesda, Maryland, January 26–28, 1973.
Lukes, R. J., Tindle, B. H.: Immunoblastic lymphadenopathy: a new hyperimmune entity resembling Hodgkin’s disease. Presented at the Workshop on Classification of Non-Hodgkin’s Lymphomas, University of Chicago, Chicago, Illinois, June 25–29, 1973.
Lukes, R., Tindle, B. H.: Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin’s disease. New Engl. J. Med. 292 ,1–8 (1975).
Tindle, B. H., Parker, J. W., Lukes, R. J.: “Reed-Sternberg Cells” in infectious mononucleosis? Am. J. Clin. Pathol. 58 ,607–617 (1972).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Lukes, R.J., Tindle, B.H. (1978). Immunoblastic Lymphadenopathy: A Prelymphomatous State of Immunoblastic Sarcoma. In: Mathé, G., Seligmann, M., Tubiana, M. (eds) Lymphoid Neoplasias I. Recent Results in Cancer Research, vol 64. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81246-0_28
Download citation
DOI: https://doi.org/10.1007/978-3-642-81246-0_28
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81248-4
Online ISBN: 978-3-642-81246-0
eBook Packages: Springer Book Archive